About Us
ViaLase® is focused on fueling the practice of noninvasive interventional glaucoma with the introduction of the world's first femtosecond laser, image-guided, high-precision trabeculotomy (FLigHT) for open-angle glaucoma.
ViaLase is singularly focused on TRANSFORMing the way Glaucoma is managed
With a leadership team that has vast experience developing and commercializing the first femtosecond lasers for ophthalmic surgery for refractive and cataract patients; ViaLase is now bringing that expertise and innovation to glaucoma patients.
MEET OUR TEAM
With over 200 years of combined experience in ophthalmology, the ViaLase team is committed to fueling the practice of noninvasive interventional glaucoma.
Tibor Juhasz, PhD
Founder and Chief Executive Officer
Dr. Tibor Juhasz has been instrumental in the development of ophthalmic applications for femtosecond lasers, including IntraLase, LenSx and ViaLase. He is a professor at the Gavin Herbert Eye Institute and the Department of Biomedical Engineering at the University of California, Irvine as well as the CEO of ViaLase. Dr. Juhasz is most known for his work on medical applications of lasers, laser-tissue interactions, tissue biomechanics, and biomedical imaging. He is the recipient of the 2002 Berthold Leibinger Innovation Prize for the development and commercialization of femtosecond laser surgical technology as well as the 2022 Golden Goose Award of the American Association for the Advancement of Science and Association of American Universities for introducing femtosecond laser technology to ophthalmology.
Tibor Juhasz, PhD
Founder and Chief Executive Officer
Dr. Tibor Juhasz has been instrumental in the development of ophthalmic applications for femtosecond lasers, including IntraLase, LenSx and ViaLase. He is a professor at the Gavin Herbert Eye Institute and the Department of Biomedical Engineering at the University of California, Irvine as well as the CEO of ViaLase. Dr. Juhasz is most known for his work on medical applications of lasers, laser-tissue interactions, tissue biomechanics, and biomedical imaging. He is the recipient of the 2002 Berthold Leibinger Innovation Prize for the development and commercialization of femtosecond laser surgical technology as well as the 2022 Golden Goose Award of the American Association for the Advancement of Science and Association of American Universities for introducing femtosecond laser technology to ophthalmology.
